Borrelia afzelii is a spirochete bacterium responsible for causing Lyme borreliosis, primarily affecting humans and rodents in the Eurasian region.
Hyperbaric oxygen therapy may enhance the body’s immune response and antibiotic effectiveness, potentially aiding in the treatment of Borrelia afzelii infections.